Stocks · Healthcare · Medical - Devices
IRadimed Corporation IRMD
$85.40 +0.12% Close, Oct 2, 2026 · NASDAQ · Market cap $1.09B
High qualityLow risk
Next earnings report: Nov 2, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- The stock is in a downtrend: below its 200-day average, with the 50-day average below the 200-day.
- Revenue over the last four quarters was $86.3M, up 11.2% from a year earlier, slowing from 14.8% a quarter earlier.
- The company holds net cash of $59.1M (cash above total debt).
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 45%
- EPS growth (TTM, YoY)Top 48%
- FCF growth (TTM, YoY)Top 19%
- Revenue growth, 3-year CAGRTop 37%
- Revenue growth accelerationBottom 29%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 5%
- Gross marginTop 35%
- Operating marginTop 6%
- Cash conversion (OCF / net income)Bottom 29%
- Accruals (lower is better)Bottom 32%
- Net debt / EBITDA (lower is better)Top 14%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 24%
- Free-cash-flow yieldTop 29%
- EBITDA / enterprise valueTop 30%
- Sales / enterprise valueBottom 27%
- P/E vs own 5-year history (lower is better)Bottom 25%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 49%
- 6-month returnBottom 30%
- 1-year return vs S&P 500Top 42%
- Distance from 52-week highTop 34%
- Trend checklist (0–4)Bottom 38%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 46%
- Consecutive EPS beatsTop 25%
- Upside to consensus price targetBottom 25%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 6%
- Maximum drawdown, 3 yearsTop 1%
- Beta vs S&P 500 (lower is better)Top 19%
- Net debt / EBITDA (lower is better)Top 14%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 14.8% | 11.2% | ↓ |
| EPS growth (YoY) | 18.1% | 10.5% | ↓ |
| Gross margin | 77.0% | 75.9% | ↓ |
| Operating margin | 30.7% | 31.9% | ↑ |
| FCF margin | 17.5% | 28.9% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 11.2% | 14.8% | ↓ | Top 45% |
| EPS growth (TTM, YoY) | 10.5% | 18.1% | ↓ | Top 48% |
| Gross margin | 75.9% | 77.0% | ↓ | Top 35% |
| Operating margin | 31.9% | 30.7% | ↑ | Top 6% |
| Net margin | 26.7% | 26.6% | ↑ | — |
| Free-cash-flow margin | 28.9% | 17.5% | ↑ | — |
| Return on invested capital | 20.2% | — | Top 5% | |
| Revenue growth, 3-year CAGR | 16.3% | — | Top 37% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 1.18×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -3.6%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 2.5%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +9.6 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- -1.90×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 1.45%
- Net buyback yield (TTM)
- 0.00%
- Shareholder yield
- 1.45%
- Share count change, 1 year
- +0.3%
- Share count change, 3-year CAGR
- +0.4%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Jul 31, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 3
- Beats in the last 8 reports
- 5 of 8
- Average EPS surprise, last 4
- +5.4%
- Average 2-day reaction, last 8
- +1.9%
- Positive 20 days after report
- 6 of 8
Analysts
- Consensus price target
- $100.00
- Target vs current price
- +17.1%
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Jul 31, 2026 | +4.5% | -4.6% | -4.2% | -8.6% | — |
| May 1, 2026 | +8.9% | +4.4% | +4.0% | +8.7% | +13.7% |
| Feb 10, 2026 | +10.2% | +9.6% | +4.9% | +3.1% | -10.1% |
| Nov 3, 2025 | -2.1% | +9.5% | +9.8% | +20.2% | +29.1% |
| Aug 1, 2025 | +8.9% | +13.4% | +18.2% | +25.2% | +34.5% |
| May 5, 2025 | -2.3% | -2.2% | -3.0% | +8.1% | +9.2% |
| Feb 13, 2025 | -2.2% | -8.4% | -5.5% | -14.9% | -14.3% |
| Oct 31, 2024 | +10.3% | -6.9% | +6.2% | +1.2% | +13.1% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Jul 31, 2026 | $0.46 | $0.44 | +4.5% | $20.5M |
| May 1, 2026 | $0.49 | $0.45 | +8.9% | $22.0M |
| Feb 10, 2026 | $0.54 | $0.49 | +10.2% | $22.7M |
| Nov 3, 2025 | $0.47 | $0.48 | -2.1% | $21.2M |
| Aug 1, 2025 | $0.49 | $0.45 | +8.9% | $20.4M |
| May 5, 2025 | $0.42 | $0.43 | -2.3% | $19.5M |
| Feb 13, 2025 | $0.44 | $0.45 | -2.2% | $19.4M |
| Oct 31, 2024 | $0.43 | $0.39 | +10.3% | $18.3M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 47.7× | 38.7× | 71th | Top 24% |
| P/E (forward) | 40.4× | — | — | — |
| EV / EBITDA | 33.2× | — | — | Top 30% |
| EV / Sales | 11.96× | — | — | Bottom 27% |
| Free-cash-flow yield | 2.28% | — | — | Top 29% |
| Earnings yield | 2.10% | — | — | Top 24% |
P/E over the past five years
Range 28.0× – 98.1× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- +21.3%
- Earnings per share growth (TTM)
- +10.5%
- Change in P/E multiple
- +24.3%
Most of the move came from a change in the valuation multiple.
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -5.3%
- 200-day average slope (20 days)
- -0.9%
- Distance from 50-day average
- -2.3%
- Distance from 200-day average
- -8.8%
- RSI (14)
- 48.7
- Relative volume
- 0.83×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 26.7%
- Volatility vs own 5-year history
- 4th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.57
- Correlation with S&P 500
- 0.28
- Current drawdown from 1-year high
- -18.8%
- Maximum drawdown, 3 years
- -22.3%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Mar 28, 2022 | Oct 13, 2022 | -49.4% | 138 days | 519 days (Nov 6, 2024) |
| Jan 4, 2022 | Jan 27, 2022 | -27.3% | 16 days | 8 days (Feb 8, 2022) |
| Feb 5, 2025 | Apr 8, 2025 | -22.3% | 43 days | 79 days (Aug 1, 2025) |
| Feb 10, 2026 | Sep 10, 2026 | -22.1% | 146 days | Not yet recovered |
| Feb 8, 2022 | Mar 14, 2022 | -14.3% | 23 days | 10 days (Mar 28, 2022) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $1.09B
- P/E (TTM)
- 47.7
- EPS, diluted (TTM)
- $1.79
- Revenue (TTM)
- $86.3M
- Dividend yield
- 1.49%
- 52-week range
- $69.47 – $107.90
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $41.8M | $53.3M | $65.6M | $73.2M | $83.8M |
| Gross profit | $32.0M | $41.3M | $50.2M | $56.3M | $64.3M |
| Operating income | $9.8M | $15.6M | $20.0M | $22.0M | $26.1M |
| Net income | $9.3M | $12.8M | $17.2M | $19.2M | $22.5M |
| EPS (diluted) | $0.74 | $1.02 | $1.35 | $1.50 | $1.75 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $18.3M | $19.4M | $19.5M | $20.4M | $21.2M | $22.7M | $22.0M | $20.5M |
| Net income | $5.0M | $5.1M | $4.7M | $5.8M | $5.6M | $6.4M | $5.8M | $5.2M |
| EPS (diluted) | $0.40 | $0.40 | $0.37 | $0.45 | $0.43 | $0.50 | $0.45 | $0.41 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $11.3M | $10.0M | $13.5M | $25.6M | $24.9M |
| Capital expenditure | -$741,759 | -$1.9M | -$8.0M | -$8.0M | -$7.8M |
| Free cash flow | $10.5M | $8.2M | $5.5M | $17.6M | $17.2M |
| Dividends paid | $0 | -$12.6M | -$13.2M | -$13.7M | -$15.0M |
| Net share buybacks | $0 | $0 | $0 | $29,618 | $0 |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $59.1M
- Total assets
- $115.0M
- Total liabilities
- $13.2M
- Total debt
- $0
- Net debt
- -$59.1M
- Shareholders’ equity
- $101.7M
As of Jun 30, 2026 (filed Jul 31, 2026).
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| Aug 14, 2026 | $0.20 | Aug 28, 2026 |
| May 15, 2026 | $0.20 | May 29, 2026 |
| Feb 23, 2026 | $0.20 | Mar 6, 2026 |
| Dec 17, 2025 | $0.50 | Dec 30, 2025 |
| Nov 14, 2025 | $0.17 | Nov 25, 2025 |
| Aug 18, 2025 | $0.17 | Aug 28, 2025 |
| May 20, 2025 | $0.17 | May 30, 2025 |
| Feb 24, 2025 | $0.17 | Mar 5, 2025 |
Short interest
- Shares sold short
- 700,005
- Days to cover
- 5.70
- Change vs previous report
- +0.4%
FINRA short interest, settlement date Sep 15, 2026.